INSULIN Act of 2026

Plain-English Summary

This bill aims to make insulin more affordable for people who rely on it to manage diabetes. While the full text details are limited, the bill's title indicates it would work to lower the price that patients pay for insulin and put in place certain protections to shield people from high out-of-pocket costs. Insulin is a life-sustaining medication that many Americans with Type 1 and Type 2 diabetes need every day, and its rising cost has been a significant financial burden for millions of people.

The bill would likely affect diabetic patients across the country, particularly those who are uninsured, underinsured, or enrolled in health plans that require high cost-sharing for prescription drugs. Patient protections included in the bill could mean things like capping how much a person has to pay for insulin each month, regardless of their insurance situation, or requiring that insulin be covered more affordably under health plans. Pharmaceutical companies, insurance providers, and pharmacy benefit managers could also be impacted depending on how the bill structures its pricing rules.

Currently, the bill has been introduced in the Senate and sent to the Committee on Health, Education, Labor, and Pensions, which is the standard first step in the legislative process. The committee will review the bill before deciding whether to advance it further. It is worth noting that similar insulin pricing legislation has been debated in recent years, reflecting ongoing concern from lawmakers on both sides of the aisle about the affordability of this essential medication.